COBAS? AMPLIPREP/COBAS? TAQMAN? HBV TEST, V2.0 CE-IVD 04894570190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2010-12-08 for COBAS? AMPLIPREP/COBAS? TAQMAN? HBV TEST, V2.0 CE-IVD 04894570190 manufactured by Roche Molecular Systems.

Event Text Entries

[15848521] (b)(4) -performance tests performed. (b)(4) - configuration issue. (b)(4) - device incorrectly prepared for use or modified. Additional information; device evaluation. Urgent medical device correction additional information provided. Roche molecular diagnostics has confirmed an issue regarding liquid level detection of the cs1 magnetic glass particles (mgp) reagent cassette of the cobas ampliprep/cobas taqman (cap/ctm) hbv v2. 0 test on the cobas ampliprep instrument. The test definition files (tdf) for cap/ctm hbv v2. 0 do not have level detection activated for the cs1 (mgp) reagent cassette. In the event that a cs1 reagent cassette is misassembled and no mgp reagent is present, it would not be detected when using the cap/ctm hbv v2. 0 test. The load check would not recognize the missing reagent and the run would continue, with the possibility of producing erroneous but believable results. The following assays are affected: cobas ampliprep-cobas taqman hbv v 2. 0 us-ivd, m/n (b)(4). Cobas ampliprep - cobas taqman hbv v 2. 0 ce-ivd, m/n (b)(4). The misassembled reagent cassette is believed to be a single occurrence, caused by human error. (b)(4). The test definition files for the cap/ctm hbv v2. 0 test will be updated with liquid level detection for the cs1 reagent cassette activated. This corrective action will prevent the issue from recurring. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[20746817] A customer from (b)(6) filed a complaint alleging that the mgp (magnetic glass particle) reagent bottle was misplaced within cassette 1 (cs1) of a kit cap-g/ctm hbv v2. 0 72tests ce-ivd (m/n 04894570190; lot n05553). Unflagged results were generated with this cassette and no error messages were generated even though the cobas ampliprep instrument was not pipetting any mgp reagent.
Patient Sequence No: 1, Text Type: D, B5


[20814489] The issue is under investigation. No conclusions can be drawn at this time. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2010-00045
MDR Report Key1917263
Report Source01,05
Date Received2010-12-08
Date of Report2010-11-09
Date of Event2010-11-07
Date Mfgr Received2010-11-09
Date Added to Maude2012-01-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Manufacturer G1ROCHE MOLECULAR SYSTEMS
Manufacturer Street1080 US HWY 202
Manufacturer CityBRANCHBURG NJ 08876373
Manufacturer CountryUS
Manufacturer Postal Code08876 3733
Single Use0
Remedial ActionRC
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS? AMPLIPREP/COBAS? TAQMAN? HBV TEST, V2.0 CE-IVD
Generic NameHEPATITIS VIRAL B DNA DETECTION
Product CodeMKT
Date Received2010-12-08
Catalog Number04894570190
Lot NumberN05553
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HWY 202 BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2010-12-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.